Expression of both the long SLFN5, which targets to the nucleus, and the intermediate SLFN12, which targets to the cytosol, is correlated with survival, tumor growth, and metastasis in triple negative breast cancer [14,73,74]. Here, SLFN5 is linked to neoplasm.